Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,015,459 | 1,651,594 | 405,278 | 1,757,090 | 1,276,067 |
| Depreciation Amortization | 620,902 | 423,654 | 215,103 | 831,312 | 650,839 |
| Income taxes - deferred | 80,129 | 3,406 | -10,014 | -229,503 | -54,199 |
| Accounts receivable | -293,959 | -508,921 | -581,112 | -97,485 | -42,522 |
| Accounts payable and accrued liabilities | 52,019 | 39,735 | 110,728 | -124,757 | -37,181 |
| Other Working Capital | -244,309 | 18,781 | -527,181 | 1,367,497 | 983,344 |
| Other Operating Activity | -811,413 | -899,767 | 332,120 | -1,026,750 | -820,889 |
| Operating Cash Flow | $1,418,828 | $728,483 | $-55,078 | $2,477,404 | $1,955,459 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -816,778 | -531,273 | -268,446 | -950,848 | -721,615 |
| Net Acquisitions | 1,166,173 | 1,570,552 | -222,786 | -169,891 | -466,742 |
| Other Investing Activity | 0 | -1 | 0 | 0 | 0 |
| Investing Cash Flow | $349,395 | $1,039,278 | $-491,233 | $-1,120,739 | $-1,188,358 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -142,281 | 364,785 | 369,479 | 639,835 | 650,222 |
| Debt Issued | 727,326 | 132,598 | 130,171 | 658,186 | 686,368 |
| Debt Repayment | 709,614 | -299,228 | -18,471 | -1,242,572 | -1,169,836 |
| Common Stock Issued | -343,688 | 6,964 | 691 | 53,792 | 45,954 |
| Common Stock Repurchased | 51,674 | -44,390 | N/A | -65,487 | N/A |
| Dividend Paid | -377,689 | -387,402 | N/A | -332,278 | -345,507 |
| Other Financing Activity | -1,478,578 | -709,903 | -66,599 | -614,167 | -519,529 |
| Financing Cash Flow | $-853,622 | $-936,576 | $415,271 | $-902,692 | $-652,327 |
| Exchange Rate Effect | -12,412 | -20,990 | -30,884 | -149,666 | -90,848 |
| Beginning Cash Position | 1,137,247 | 1,166,493 | 1,202,292 | 801,249 | 833,149 |
| End Cash Position | 2,039,436 | 1,976,688 | 1,040,368 | 1,105,557 | 857,076 |
| Net Cash Flow | $902,189 | $810,195 | $-161,924 | $304,307 | $23,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,418,828 | 728,483 | -55,078 | 2,477,404 | 1,955,459 |
| Capital Expenditure | -851,049 | -555,640 | -272,251 | -1,067,523 | -743,177 |
| Free Cash Flow | 567,779 | 172,844 | -327,329 | 1,409,881 | 1,212,282 |